Nanotechnology in Drug Delivery - The Nanobiotechnology - page 533

Speiser,.P..P..1998..Poorly.soluble.drugs:.A.challenge.in.drug.delivery..In. Emulsions and Nanosuspensions
for the Formulation of Poorly Soluble Drugs ,.Muller,.R..H.,.S..Benita,.and.B..H..L..Bohm..Stuttgart,.
Germany:.MedPharm.Scientiic.Publishers.
Suman,. K.,. V.. S.. R.. P.. Chandrasekhar,. and. S.. Balaji.. 2009.. Drug. nanocrystals:.A. novel. formulation.
approach.for.poorly.soluble.drugs.. International Journal of PharmTech Research .1(3):682-694.
Thies,. J.. and. B.. W.. Müller.. 1998.. Size. controlled. production. of. biodegradable. microparticles. with.
supercritical.gases.. European Journal of Pharmaceutics and Biopharmaceutics .45(1):67-74.
Violante,.M..R..and.Fischer;.H..W..1991..Method.for.making.uniformly-sized.particles.from.insoluble.
compounds..In. United States Patent ..Rochester,.NY:.The.University.of.Rochester.
Vishnu,. P.. and. V.. Roy.. 2011.. Safety. and. eficacy. of. nab-paclitaxel. in. the. treatment. of. patients. with.
breast.cancer.. Breast Cancer: Basic and Clinical Research .5:53-65.
Xie,. H.. and. J.. W.. Smith.. 2010.. Fabrication. of. PLGA. nanoparticles. with. a. luidic. nanoprecipitation.
system.. Journal of Nanobiotechnology .8:18.(7pp).
Yeh,. P.,. H.. Ellens,. and. P.. L.. Smith.. 1998.. Physiological. considerations. in. the. design. of. particulate.
dosage.forms.for.oral.vaccine.delivery.. Advanced Drug Delivery Reviews .34(2-3):123-133.
Zara,.G..P.,.R..Cavalli,.A..Fundaro.et.al..1999..Pharmacokinetics.of.doxorubicin.incorporated.in.solid.
lipid.nanospheres.(SLN).. Pharmaceutical Research .40(3):281-286.
Zucker,. D.,. D.. Marcus,.Y.. Barenholz,. and.A.. Goldblum.. 2009.. Liposome. drug's. loading. eficiency:.
A.working.model.based.on.loading.conditions.and.drug's.physicochemical.properties.. Journal
of Controlled Release .139(1):73-80.